Revista Pulmão RJ – 2024 – volume: 32 – nº 2 – Processo Inflamatório Pulmonar Grave e Acelerado em Adolescente de 17 Anos: EVALI?
Processo Inflamatório Pulmonar Grave e Acelerado em Adolescente de 17 Anos: EVALI?
Severe and Accelerated Pulmonary Inflammatory Process in a 17-Year-old Teenager: EVALI?
Hisbello S. Campos1, Maiéve Corralo Grando2
Processo Inflamatório Pulmonar Grave e Acelerado em Adolescente de 17 Anos: EVALI?
RESUMO
Os autores relatam o caso de uma adolescente de 17 anos, usuária de VAPE, sem histórico de doença pulmonar prévia e radiografia do tórax normal uma semana antes do procedimento cirúrgico (implantação de próteses mamárias de silicone). Ao término do procedimento cirúrgico, no momento da extubação, apresentou broncoespasmo agudo e queda brusca da saturação da hemoglobina. A tomografia do tórax, realizada poucas horas depois, revelou opacidade em vidro fosco comprometendo pouco mais de 50% da área pulmonar. A angioTC feita dois dias depois não revelou sinais de tromboembolismo, mas mostrou processo de consolidação pulmonar em andamento. Medicada com Dexametasona e suplementação de oxigênio por VNI/cateter nasal de alto fluxo, evoluiu favoravelmente com melhoria do padrão radiológico seis dias após o início do quadro. Possivelmente, o comprometimento pulmonar reflete lesão pulmonar pelo VAPE.
PALAVRAS-CHAVE
Inflamação pulmonar; VAPE.
ABSTRACT
The authors report the case of a 17-year-old adolescent, user of VAPE, with no history of pulmonary disease and a normal chest X-ray one week before the surgical procedure (implantation of silicone breast implants). At the end of the surgical procedure, at the time of extubation, she developed acute bronchospasm and a sudden drop in hemoglobin saturation. A tomography scan of the chest, performed a few hours later, revealed a ground-glass opacity affecting just over 50% of the lung area. CT angiography performed the next day did not reveal signs of thromboembolism, but showed an ongoing process of pulmonary consolidation. Medicated with dexamethasone and supplemental oxygen via NIV/high-flow nasal catheter, she evolved favorably with radiological cleaning six days after the onset of the respiratory problem. Possibly, lung involvement reflects lung injury from VAPE.
KEY WORDS
Lung inflammation; VAPE.
1 Médico da Fiocruz. Mestre e Doutor em Medicina (Pneumologia) pela UFRJ
2 Cirurgiã plástica, Instituto Maiéve Corralo
REFERÊNCIAS
1. Bozier J, Chivers EK, Chapman DG e cols. The Evolving Landscape of e-Cigarettes: A Systematic Review of Recent Evidence. Chest 2020;157:1362–90.
2 Hambergera ES, Halpern-Felsherb B. Vaping in adolescents: epidemiology and respiratory harm. Curr Opin Pediatr. 2020 June;32(3):378–83.
3 Phillips B, Titz B, Kogel U et al. Toxicity of the main electronic cigarette components, propylene glycol, glycerin, and nicotine, in Sprague-Dawley rats in a 90-day OECD inhalation study complemented by molecular endpoints. Food Chem Toxicol 2017; 109:315–32.
4 Goniewicz ML, Smith DM, Edwards KC e cols. Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes. JAMA Netw. Open 2018, 1, e185937.
5 Bustamante G, Ma B, Yakovlev G e cols.. Presence of the Carcinogen N0-Nitrosonornicotine in Saliva of E-cigarette Users. Chem Res Toxicol 2018;31:731–738.
6 Badea M, Luzardo OP, González-Antuña e cols. Body burden of toxic metals and rare earth elements in non- smokers, cigarette smokers and electronic cigarettes users. Environ Res 2018;166:269–275.
7 Badea M, Luzardo OP, González-Antuña e cols. Body burden of toxic metals and rare earth elements in non- smokers, cigarette smokers and electronic cigarettes users. Environ Res 2018;166:269–275.
8 Sommerfeld CG, Weiner DJ, Nowalk A e col. A. Hypersensitivity Pneumonitis and Acute Respiratory Distress Syndrome from E-Cigarette Use. Pediatrics 2018;141:e20163927.
9 Layden JE, Ghinai I, Pray I e cols. Pulmonary Illness Related to E-Cigarette Use in Illinois andWisconsin — Final Report. N Engl J Med 2020;382:903–916.
10 New Cases in Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) On the Decline j CDC Online Newsroom j CDC. https://www.cdc.gov/media/releases/2019/p1220-cases-EVALI.html. Published December 20, 2019.CDC clinical guidance recommendations for e-cigarette or vaping product use-associated lung injury (EVALI).
11 American Thoracic Society – Vaping: The Threat to Public Health and the ATS Response. https://www.thoracic.org/professionals/clinical-resources/disease-related-resources/vaping-the-threat-to-public-health- and-the-ats-response.php
12 The American Academy of Pediatrics Issues Sweeping Recommendations on Tobacco and E-Cigarettes. AAP.org http://www.aap.org/en-us/about-the-aap/aap-press-room/aap-press-room-media-center/Pages/Tobacco-and-E- Cigarettes.aspx.
13 Gilman G. Analytical testing of e-cigarette aerosol. In: Farsalinos KE, Gillman IG, Thornburg JW, Hecht SS, Polosa R, editors. Analytical assessment of E-cigarettes: from contents to chemical and particle exposure profiles. Amsterdam: Elsevier; 2017. p. 9– 35.
14 Eaton DL, Kwan LY, Stratton K, editors. Public health consequences of E-cigarettes. Washington DC: The National Academies Press; 2018
15 Zhu S, Zhuang Y-L, Wong S et cols. E-cigarette use and associated changes in polutionsmoking cessation: evidence from US current population surveys. BMJ 2017;358:3262.
16 National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems; Public Health Consequences of E-Cigarettes; Eaton, D.L.; Kwan, L.Y.; Stratton, K. (Eds.) Public Health Consequences of E-Cigarettes; National Academies Press: Washington, DC, USA, 2018
17 Krishnasamy VP, Hallowell BD, Ko JY et al. Update: Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury—United States, August 2019–January 2020. MMWR Morb. Mortal. Wkly. Rep. 2020, 69, 90–94.
18 Rebuli ME, Rose JJ, Noel A et cols. The E-cigarette or vaping product use-associated lung injury epidemic: pathogenesis, management, and future directions; na oficial American Thoracic Society Workshop Report. Ann Am Thorac Soc 2023;20(1):1-17.
19 Voos N, Goniewicz ML, Eissenberg T. What is the nicotine delivery profile of eletronic cigarettes? Expert Opin Drug Deliv 2019;16(11):1193-1203.
20 Dinardo P, Rome ES. Vaping: the new wave of nicotine addiction. Cleveland Clin J Med 2019;86(12):789-98.
21 Marcham CL, Springton JP. Eletronic cigarettes in the indoor environment. Ver Env Health 2019;34(2):105-24.
22 Modesto-Lowe V, Alvarado C. E-cigarettes are They cool? Talking to teens about ecigarettes. Clin Pediatr 2017;51(10):947-52.
23 Kalra A, Ahmaed A (2019) India bans e-cigarettes as global backlash at vaping gathers pace. https://www.reuters.com/article/us-india-ecigarettes/india-bans-e-cigarettes-as-global-backlash-atvaping-gathers- pace-idUSKBN1W3.
24 O´Callaghan M, Boyle N, Fabre A et cols. Vaping-associated lung injury: a review. Medicina 2022;58(3):412.
25 Layden JE, Ghinai I, Pray I et al. Pulmonary Illness Related to E-Cigarette Use in Illinois andWisconsin—Final Report. N. Engl. J. Med. 2020, 382, 903–916.
26 Zou RH, Tiberio PJ, Triantafyllou GA et al. Clinical Characterization of E-Cigarette, or Vaping, Product Use- associated Lung Injury in 36 Patients in Pittsburgh, Pennsylvania. Am. J. Respir. Crit. Care Med. 2020, 201, 1303–1306.
27 Kalininskiy A, Bach CT, Nacca NE et al. E-cigarette, or vaping, product use associated lung injury (EVALI): Case series and diagnostic approach. Lancet Respir. Med. 2019, 7, 1017–1026.
28 O’Carroll O, Sharma K, Fabre A et al. Vaping-associated lung injury. Thorax 2020, 75,706–707.
29 Henry TS, Kanne JP, Kligerman SJ (2019) Imaging of vapingassociated lung disease. N Engl J Med 381(15):1486– 1487.
30 Henry TS et al (2020) Imaging findings of vaping-associated lung injury. AJR Am J Roentgenol 214(3):498–505.
31 – Layden JE et al (2020) Pulmonary illness related to E-cigarette use in Illinois and Wisconsin – final report. N Engl JMed 382(10):903–16.
32 Viswam D et al (2018) Respiratory failure caused by lipoid pneumonia from vaping e-cigarettes. BMJ Case Rep:2018.
33 Maryam Kaous M, Xian J, Rongo D et cols. Clinical, radiology, pathologic patterns and outcomes of vaping related pulmonary injury in a single institution; A case series. Respir Med 2020;173:106153.
34 Kligerman SJ, Kay FU, Raptis CA et cols. CT Findings and Patterns of e-Cigarette or Vaping Product Use- Associated Lung Injury A Multicenter Cohort of 160 Cases. CHEST 2021;160(4):1492-1511.
35 Thakrar PD, Boyd KP, Craig P Swanson CP et cols. E-cigarette, or vaping, product use-associated lung injury in adolescents: a review of imaging features. Pediatr Radiol 2020;50(3):338-44.
36 Chidambaram AG, Dennis RA, Biko DM et cols. Clinical and radiological characteristics of e-cigarette or vaping product use associated lung injury. Emerg Radiol 2020;27(5):495-501.
37 Henry TS, Kanne JP, Kligerman SJ. Imaging of vapingassociated lung disease. N Engl J Med 2019; 381(15):1486– 1487.
38 Henry TS et al. Imaging findings of vaping-associated lung injury. AJR Am J Roentgenol 2020;214(3):498–505.
39 Layden JE et al. Pulmonary illness related to E-cigarette use in Illinois andWisconsin – final report. N Engl J Med 2020;382(10):903–916.
40 Puliyakote ASK, Elliot AR, Sá RC et cols. Vaping disrupts ventilation-perfusion matching in asymptomatic users. J Appl Physiol 2021;130(2):308-17.
41 CDC. Severe pulmonary disease associated with using e-cigarette products. HAN alert no. 421. Atlanta, GA: US Department of Health and Human Services, CDC, Health Alert Network; 2019. https:// emergency.cdc.gov/han/han00421.asp
42 Aldy K, Cao DJ, Weaver MM, et al. E-cigarette or vaping product use-associated lung injury (EVALI) features and recognition in the emergency department. J Am Coll Emerg Physicians Open. 2020;1(5):1090-96.
43 Garg I, Vidholia A, Garg A et cols. E-cigarette or vaping product use-associated lung injury: A review of clinico- radio-pathological characteristics. Respir Investig 2022;60(6):738-49.
44 Beck LR, Landsberg D.In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan.
45 Butt YMet al. Pathology of vaping-associated lung injury. N Engl J Med 2019;381(18):1780-1.
46 Mukhopadhyay S et al. Lung biopsy findings in severe pulmonar illness associated with E-cigarette use (vaping). Am J Clin Pathol 2020;153(1):30–9.
47 Beasley MB. The pathologist’s approach to acute lung injury. Arch Pathol Lab Med 2010;134(5):719–27.
48 Alexander LEC, Perez MF. Identifying, tracking, and treating lung injury associated with e-cigarettes or vaping. Lancet 2019;394(102214):2041-3.
49 Prevention CfDCa. Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products. Available online: https://www.cdc.gov (accessed on 25 February 2021).
50 Kim JP et al. A case of diffuse alveolar hemorrhage after tonsillectomy – a case report. Korean J Anesthesia 2012; 63(2): 165-168
51 Kim Ca, Liu r, Hsia DW. Diffuse alveolar hemorrhage induced by sevoflurane. Ann Am Thorac Soc 2014;11:853– 855
52 Murray AW, Smith JD, Ibinson JW. Diffuse Alveolar Hemorrhage, Anesthesia and Cannabis. Ann Am Thorac Soc 2014; 11(8):1338-1339
53 Cavalcante AN, Gurrieri C, Sprung J et cols. Isoflurane and postoperative respiratory depression following laparoscopic surgery: A retrospective propensity-matched analysis. Bosn J Basic Med Sci. 2018 Feb 20;18(1):95-100.
54 von Ungern-Sternberg BS, Saudan S, Petak F et cols. Desflurane but Not Sevoflurane Impairs Airway and Respiratory Tissue Mechanics in Children with Susceptible Airways. Anesthesiology 2008; 108:216–24
